http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102872070-B
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fcc35f152994b9dd00422a05c7e7572f |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7048 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-08 |
filingDate | 2012-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2013-08-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5ed7b2f60646f61b214ffebb865618a6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6298f3c1c727b5eb69931702f64a99bf http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bd9757c3ce1247c0bc12193da23a4adb |
publicationDate | 2013-08-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-102872070-B |
titleOfInvention | Application of Houttuynoid C to preparing drugs for treating prostate cancer |
abstract | The invention discloses application of Houttuynoid C to preparing drugs for treating prostate cancer, belonging to the technical field of new uses of the drugs. According to the invention, found by in vitro methyl thiazolyl tetrazolium (MTT) antineoplastic activity evaluation, Houttuynoid C also has remarkable inhibition effect on the growth of human prostate cancer cell lines ALVA, gpc-1, 9L-B and Du 145. Therefore, Houttuynoid C can be used for preparing the drugs for resisting the prostate cancer and has good development and application prospects. The application of Houttuynoid C to preparing the drugs for treating the prostate cancer, disclosed by the invention, is firstly published; the framework type is brand new; and the activity of inhibiting the prostate cancer cells is unexpectedly strong. |
priorityDate | 2012-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 19.